Skip to main content
WADA Banned 787 views

BPC-157

Body Protection Compound for accelerated tissue healing and repair

BPC-157 molecular structure

WADA BANNED - Prohibited in competitive sports as healing peptide

Overview

BPC-157, short for Body Protection Compound-157, is a 15-amino acid peptide naturally found in human gastric (stomach) juice. Think of it as your body's built-in repair mechanism, amplified. **What does it do?** Research shows BPC-157 acts like a cellular "handyman" — it helps your body repair damaged tissues faster, whether that's tendons, ligaments, muscles, or your gut lining. It works by boosting blood vessel formation (angiogenesis) and stimulating the production of collagen, the protein that holds your tissues together. **Key research findings:** • Accelerates healing of soft tissue injuries in animal studies • Protects and heals the gastrointestinal tract • May help counteract damage from NSAIDs (like ibuprofen) • Phase II clinical trials for ulcerative colitis showed no significant side effects • No lethal dose has been established in toxicology studies **Important to know:** While animal research is extensive and promising, human clinical studies remain limited. Most evidence comes from rodent and cell studies. --- **Sources:** Seiwerth S, et al. (2018) Current Pharmaceutical Design. DOI:10.2174/1381612824666180712110447 | Gwyer D, et al. (2019) Cell Tissue Research. DOI:10.1007/s00441-019-03016-8 | Kang EA, et al. (2024) Inflammopharmacology. DOI:10.1007/s10787-024-01499-8

Last reviewed: 2026-08-18

Identity & Aliases

Also known as

BPC 157Body Protection Compound-157Stable gastric pentadecapeptide BPC 157Pentadecapeptide BPC 157PL 14736

Status: Investigational - Not approved for human use

CAS137525-51-0
PubChem9941957

Full composition (formula, molecular weight, sequence) in Quick Facts →

Research Areas

Gastrointestinal mucosal protection and healingTendon, ligament and muscle healingWound healing and angiogenesisAnti-inflammatory effects

Available Evidence

Human

No FDA approval and no large randomized controlled trials in humans were identified; published human evidence is essentially absent, with use limited to unregulated/off-label settings.

Animal

Extensive rat studies (mainly from the Zagreb group) show BPC 157 accelerates healing of transected Achilles tendon, improves tendon-to-bone healing at the myotendinous junction, protects gastrointestinal mucosa (Robert's cytoprotection paradigm), and modulates nitric oxide pathways.

In Vitro

In vitro studies report stimulation of tendon cell (tenocyte) growth and pro-angiogenic effects.

Uncertain

Claims of systemic 'whole-body healing', athletic recovery benefits and specific human dosing protocols are not supported by published clinical trials.

Key Studies & Findings

4 studies
Preclinical2022

Review of BPC 157 in striated, smooth and heart muscle summarizes tissue-protective and healing effects across rat muscle injury models.

Preclinical2020

Review positions BPC 157 within Robert's gastric cytoprotection/organoprotection and stress-coping framework, summarizing gastrointestinal protection data.

Benefits & Effects

15 documented

Accelerated wound healing

anecdotal

Tendon and ligament repair

anecdotal

Muscle tissue regeneration

anecdotal

Anti-inflammatory effects

anecdotal

Gastrointestinal protection

anecdotal

Accelerated healing

anecdotal

Tissue repair

anecdotal

Anti-inflammatory

anecdotal

Gut health support

anecdotal

Injury recovery

anecdotal

Angiogenesis promotion

anecdotal

Gastrointestinal Protection: Anti-ulcer activity throughout GI tract, heals anastomoses

clinical

Wound Healing: Promotes skin, tendon, ligament, and GI tract healing via VEGF/angiogenesis pathways

clinical

Tendon/Ligament Repair: FAK-paxillin pathway activation; accelerates Achilles tendon healing

clinical

Vascular Protection: Prevents thrombosis, promotes collateral circulation

clinical

Side Effects & Safety

17 reported

110 μg for a 150lb person

145 μg for a 200lb person

180 μg for a 250lb person

No toxicity reported

Mild

No adverse reactions documented

Mild

No human trial toxicity

Mild

Nausea

MildUncommon

Dizziness

MildUncommon

Fatigue

MildUncommon

Increased appetite

MildUncommon

Local irritation

MildUncommon

Rare systemic effects

SevereRare

Decreased appetite

MildUncommon

Rare pancreatitis

SevereRare

GI upset (nausea, diarrhea, vomiting)

MildUncommon

Side effect reported

0% (n=2 pilot study)

Management: No intervention needed

Mild side effect

MildRare Reversible

Onset: During dosing

Management: Self-resolving after discontinuation

Dose-dependent

Limitations & Open Questions

Evidence is dominated by a single research group's animal models with limited independent replication; no adequately powered randomized human trials exist; mechanism (angiogenesis, nitric oxide modulation) remains incompletely characterized; formulation, dosing and long-term human safety are unestablished.

Pharmacology

Pentadecapeptide (15 amino acids) derived from a human gastric juice protein; reported to be stable in gastric juice. Human pharmacokinetics (half-life, bioavailability) are not established; typically administered parenterally in research settings. Proposed mechanism involves nitric oxide pathway modulation and angiogenesis.

Reported Research Dosing

Reported values from research literature and community protocols. Educational reference only — not a dosing recommendation or medical advice.

200-500 mcg Daily

Route: SC/Oral
Half-life: <30 minutes

Research Protocols

Tendon/Joint healing

Dose
250-500mcg
Frequency
1-2x daily
Route
SubQ near injury

Serious injury

Dose
500-1000mcg
Frequency
2x daily
Route
SubQ near injury

General healing

Dose
250-500mcg
Frequency
1-2x daily
Route
SubQ or IM

Maintenance

Dose
250mcg
Frequency
1x daily
Route
SubQ

Research protocols are for educational purposes only. Always consult qualified medical professionals.

Frequently Asked Questions

Is BPC-157 FDA-approved?

No. It is not an approved drug anywhere; human use is off-label/research and largely unregulated.

Does BPC-157 work for tendon injuries?

Animal studies show accelerated tendon healing in rats, but human clinical confirmation is lacking.

Research Citations

Related Resources

Quick Facts

Formula

C62H98N16O22

Molecular Weight

1419.53

Sequence

GEPPPGKPADDAGLV

Mechanism

Promotes angiogenesis and tissue healing

Safety Information

No human clinical trials completed. Research compound only - not for human consumption.

View All Peptides